Deltex Medical is a British specialist in Fluid Management technology. At its core is esophageal Doppler hemodynamic monitoring (EDM) at the heart of its recently rebranded TrueVue system. From its head office and manufacturing base in Chichester, West Sussex, UK, the company now has subsidiaries in the USA, Canada and Spain.
Deltex’s mission is to benefit patients and healthcare providers by making EDM the standard of care wherever possible. We’re passionate about this because the evidence tells us that use of EDM to guide fluid and drug administration results in better outcomes.
The principle is that by accurately monitoring and managing a patient’s hemodynamic status, the risk of complications is minimized. This is proven to translate into longer life, shorter hospital stay and reduced cost of care.
From its earliest days, back in 1992, Deltex has enjoyed watching and participating in the building of an unsurpassed, robust evidence base. It is a compelling story of clinical benefit and cost-effectiveness that is helping the company to achieve system-wide adoption of this unique medical technology.
We’re working hard on our mission across the world. There are already over 3,000 EDM systems in use in hospitals globally with distribution in over 30 countries.
Deltex Medical’s heartland in human surgery and critical care now also extends into the veterinary world where the benefits of being able to “see” every heartbeat means once more we can help clinicians to deliver the very best outcomes from small animal interventions.
